Cargando…
Mucosal Vaccines from Plant Biotechnology
The use of plants for production of recombinant proteins has evolved over the past 25 years. The first plant-based vaccines were expressed in stably transgenic plants, with the idea to conveniently deliver “edible vaccines” by ingestion of the antigen-containing plant material. These systems provide...
Autores principales: | Mason, Hugh S., Thuenemann, Eva, Kiyono, Hiroshi, Kessans, Sarah, Matoba, Nobuyuki, Mor, Tsafrir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158328/ http://dx.doi.org/10.1016/B978-0-12-415847-4.00065-3 |
Ejemplares similares
-
Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana
por: Kessans, Sarah A, et al.
Publicado: (2013) -
P02-10. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1
por: Kessans, SA, et al.
Publicado: (2009) -
Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles
por: Kessans, Sarah A., et al.
Publicado: (2016) -
P12-16. Biochemical and immunological characterization of the plant-derived candidate HIV-1 mucosal vaccine CTB-MPR
por: Matoba, N, et al.
Publicado: (2009) -
Transgenic Plants for Mucosal Vaccines
por: Mason, Hugh S., et al.
Publicado: (2005)